×
Eli Lilly's Mirikizumab Shows Promise in Treating Crohn's Disease, Faces Competition from AbbVie's Skyrizi

Eli Lilly’s Mirikizumab Shows Promise in Treating Crohn’s Disease, Faces Competition from AbbVie’s Skyrizi

The phase III VIVID-1 study demonstrated exceptional potential, meeting all primary and secondary benchmarks over a 52-week treatment span. Eli Lilly has unveiled promising results for its experimental drug, mirikizumab (Omvoh), in the treatment of moderate-to-severe Crohn’s disease (CD) Impressively, 51.4% of CD patients achieved clinical remission on the drug, a substantial surge compared to…

Read More
Rising Epidemic: Debilitating Chronic Pain Afflicts Millions in the U.S.

Rising Epidemic: Debilitating Chronic Pain Afflicts Millions in the U.S.

A staggering 20.9% of adults in the United States, totaling 51.6 million individuals, grapple with this enduring discomfort as of 2021, with numbers steadily climbing. Debilitating chronic pain has become a pervasive challenge for a substantial portion of Americans, surpassing the prevalence of conditions like depression, high blood pressure, and diabetes Debilitating chronic pain persists…

Read More
Gavin Christopher Newsom

Gavin Christopher Newsom Unveils Ambitious Mental Health and Homelessness Reforms in California

On Thursday, the Democratic governor signed two pivotal pieces of legislation, both slated for voter consideration in 2024. California Governor Gavin Christopher Newsom has taken significant steps to revamp the state’s mental health system and combat its escalating homelessness crisis To implement these initiatives, Governor Gavin Christopher Newsom is seeking voters’ approval to secure a…

Read More
Autism

How Inflammatory Brain Disease Can Develop Autism And Other Neurodevelopment Disorders In Young Children

How can an inflammatory brain disease develop autism and other neurodevelopment disorders in young children? Inflammatory Brain Disease Can Cause Autism Development and Other Neurodevelopment Disorders in Young Children An inflammatory brain disease can reportedly cause the development of autism and other neurodevelopment disorders in young children as the inflammatory brain disease can negatively affect…

Read More
New RSV Shot

New RSV Shot To Protect Babies And Young Children From Virus Following Increasing RSV Cases

The new RSV shot will protect babies and young children from the virus following the increasing number of RSV cases. New RSV Shot Coming to Protect Babies and Young Children from Life-Threatening Virus Following High Cases The new RSV shot approved will aim to protect babies and young children from the life-threatening virus following the…

Read More
GLP-1 Medications

GLP-1 Medications: Study Reveals Risks and Benefits for Weight Loss

These GLP-1 medications emulate the natural GLP-1 hormone found in the small intestine, influencing various aspects of metabolism. GLP-1 medications, known as Glucagon-like peptide-1 receptor agonists, are a class of drugs employed in the management of type 2 diabetes They stimulate the pancreas to release insulin, inhibit the secretion of glucagon, which elevates blood sugar,…

Read More